It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Denmark is the latest in a series of countries that President-elect Donald Trump has threatened with tariffs — joining a list ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
38m
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...
Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback